Immunotherapy
This session will introduce immunotherapy and review the mechanism of action of immune check point inhibitors. Testing and interpretation of PD-L1 and PD-L, MSI-H, dMMR, TMB, CPS will also be discussed. Immunotherapy specific to gynecologic oncology will be highlighted as well as dosing, administration of immunotherapy, and how to manage adverse effects from therapy.
Speaker: Thomasina Morris, RPh, MHA, BCOP
Available Credit
- 0.75 AMA PRA Category 1 Credit™In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this Enduring material for a maximum of 0.75 Enduring AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 0.75 AMA PRA Category 1 Credits™- For Non-physiciansIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PAs may claim a maximum of 0.75 Enduring Category 1 credits for completing this activity. - 0.75 CNE Contact HoursIn support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society of Gynecologic Oncology (SGO). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco LLC designates this activity for a maximum of 0.75 Enduring ANCC contact hours. - 0.75 Participation